Shanghai Runshi Pharmaceutical Technology Co., Ltd
Registry sponsor category
Industry
- Other names
- Shanghai Runshi Pharmaceutical Technology Co., Ltd
- Company name
- Shanghai Runshi Pharmaceutical Technology Co., Ltd
- Organisation type
- Industry
- Registry sponsor category
- Industry
- Publicly traded (proxy)
- No
- Listing at source
- Listed
Related records
Trials (10)
- A Phase I Trial of Simmitinib in Advanced Solid Tumors
- A Phase II Study of SYHA1813 for Recurrent or Progressive High-Grade Meningioma
- A Phase III Study of SYHA1813 for Recurrent or Progressive High-Grade Meningiomas
- A PhaseⅠ/Ⅱ Study of Simmitinib or Irinotecan Liposomes Combined With DP303c in Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma
- A Study of Simmitinib Plus Irinotecan in Advanced Esophageal Squamous Cell Carcinoma
- A Study of Simmitinib Plus SG001 in Advanced Solid Tumors
- A Study of Simmitinib Versus Chemotherapy for Participants With Advanced Oesophageal Squamous Cell Carcinoma
- A Study to Investigate the Safety of SYHA1815 in Subjects With Unresectable Locally Advanced or Metastatic Solid Tumors
- Relative Bioavailability and Food Effect of SYHA1813 Oral Solution in Healthy Participants
- Safety and Efficacy of SYHA1813 Single Agent or in Combination With Different Regimens in Unresectable Locally Advanced or Metastatic Solid Tumors.